Recruiting

Lifeblood

Sponsor:

Efforia, Inc

Code:

NCT07293117

Conditions

Energy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Heart & Soil Lifeblood

Study Details

Brief summary:

This study explores how Heart \& Soil's Lifeblood impacts iron levels and energy.

Conditions

Energy

Study ID

NCT07293117

Start date

Sep 9, 2025

Status verified date

Dec, 2025

Completion date

Sep 9, 2026

Anticipated

Primary completion date

Sep 9, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Exclusion Criteria:

  • Individuals with Hemochromatosis
  • Individuals with Severe Allergies
  • Pregnant or Nursing Women
  • Individuals with Gastrointestinal Disorders
  • Individuals on Iron-Related Medications
  • Individuals with Mental Health Disorders
  • Competitive Athletes

Study Design

Enrollment

100 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Single arm where participants act as their own control

Single Arm observational where participants act as their own control

Interventions

Heart & Soil Lifeblood

Lifeblood is an iron and blood-supporting supplement made of liver, spleen, and whole blood extract.

Primary outcome measure

  • Fatigue Perception and Impact Survey [ Time Frame: Change from baseline (Day 1-7) in fatigue perception and impact at 4 to 5 weeks after the start of the intervention ]
  • Iron and Ferritin Blood Levels [ Time Frame: Change from baseline (Day 1-10) in iron and ferritin blood levels at 11 to 14 weeks after the start of the intervention ]

Central Contacts and Locations

Central contacts

Matthew Amsden

646-679-2479help@efforia.com

Locations

Efforia

Recruiting

New York, New York, United States, 10003

Contacts

Matthew Amsden

(646) 679-2479help@efforia.com

More Information

Sponsor

Efforia, Inc

Last update posted

Dec 26, 2025

Last verified

Dec, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Efforia, Inc on 2025-12-26.